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The lung alveolar region experiences remodeling during several acute and chronic lung
diseases, as for instance idiopathic pulmonary fibrosis (IPF), a fatal disease, whose onset
is correlated with repetitive microinjuries to the lung alveolar epithelium and abnormal
alveolar wound repair. Although a high degree of mechanical stress (>20% linear strain) is
thought to potentially induce IPF, the effect of lower, physiological levels of strain (5–12%
linear strain) on IPF pathophysiology remains unknown. In this study, we examined the
influence of mechanical strain on alveolar epithelial wound healing. For this purpose, we
adopted the “organ-on-a-chip” approach, which provides the possibility of reproducing
unique aspects of the in vivo cellular microenvironment, in particular its dynamic nature.
Our results provide the first demonstration that a wound healing assay can be performed
on a breathing lung-on-a-chip equipped with an ultra-thin elastic membrane. We
cultured lung alveolar epithelial cells to confluence, the cells were starved for 24 h,
and then wounded by scratching with a standard micropipette tip. Wound healing was
assessed after 24 h under different concentrations of recombinant human hepatic growth
factor (rhHGF) and the application of cyclic mechanical stretch. Physiological cyclic
mechanical stretch (10% linear strain, 0.2Hz) significantly impaired the alveolar epithelial
wound healing process relative to culture in static conditions. This impairment could be
partially ameliorated by administration of rhHGF. This proof-of-concept study provides
a way to study of more complex interactions, such as a co-culture with fibroblasts,
endothelial cells, or immune cells, as well as the study of wound healing at an air–liquid
interface.
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INTRODUCTION
An organ-on-a-chip (OOC) is an advanced in vitro system that provides cells with an environment
that closely resembles their in vivomilieu (Benam et al., 2015). In such environments, cells maintain
their original functions and respond to external stimuli, such as mechanical forces or therapeutic
compounds, as if they were within the tissues of the body. OOCs also recapitulate aspects of
healthy and diseased cellular environments, allowing investigation of fundamental biological
questions. In contrast to in vivo studies, OOCs make it possible to individually assess the effects
of specific parameters of the microenvironment. Thus, OOCs are promising tools for improving
and accelerating drug development, as well as obtaining deeper insights into pathophysiological
processes (Chan et al., 2013; Sackmann et al., 2014; Esch et al., 2015).
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Idiopathic pulmonary fibrosis (IPF) is a chronic, fatal lung
disease characterized by an abnormal wound healing and
remodeling process of alveolar epithelial cells (King et al., 2011).
The various aspects of the disease and the lack of predictive in
vivo and in vitromodels make IPF difficult to study. It is generally
accepted that IPF is initiated by repetitive microinjuries to the
alveolar epithelium. Aberrant repair of those injuries is followed
by a fibro-proliferative response that induces progressive scarring
of the lung parenchyma, ultimately leading to respiratory failure.
Although the cause of these microinjuries, as well as the cause
of aberrant wound healing, remains unknown, it is thought
that mechanical forces play important roles in the development
and progression of IPF (Selman and Pardo, 2014). In particular,
scarring of the lungs occurs with higher probability at the base
and periphery, where mechanical forces due to breathing are
greatest. Under physiologic conditions, alveolar regions of the
lungs are exposed to a linear strain of up to 12% (Waters et al.,
2012). However, scarred areas are less elastic than the healthy
elastic regions and must compensate for the strain, resulting in
highermechanical stretch in those areas. Highmechanical stretch
causes apoptosis and slows wound repair in rat alveolar epithelial
cells and decreases cell migration in bronchial 16HBE-14o-cells
(Desai et al., 2008; Crosby et al., 2011). In addition, wound
repair of primary human alveolar epithelial cells is delayed under
physiologic (10%) linear strain (Ito et al., 2014). Thus far, the
in vitro systems used to investigate wound healing have been
based on stiff, Petri dish–based systems or stretchable systems
assembled on thick silicone substrates (Guenat and Berthiaume,
2018). We recently demonstrated that microfluidics platforms
enable investigation of alveolar epithelial microinjuries more
reproducibly and at a smaller scale (Felder et al., 2012, 2014). The
hypothesis that gastro-esophageal reflux is a source of repetitive
microinjuries was also investigated on a chip (Felder et al., 2014).
Here, we report the use of a microengineered lung-on-a-chip
(Stucki et al., 2015, 2018) with a “breathing” ultra-thinmembrane
to investigate the effects of cyclic mechanical stress induced by
respiratory motions on alveolar wound repair. The open design
of the lung-on-a-chip enabled the use of a scratch assay to create
microinjuries in the intact alveolar epithelium. The epithelium
was further exposed to hepatic growth factor, which promotes
alveolar epithelial wound healing (Felder et al., 2012). The results
confirmed that physiological mechanical stress affects alveolar
wound closure. These results are a first step toward recapitulating
the complex interplay of wound repair in the alveolar epithelium.
METHODS
Fabrication of the Lung-On-A-Chip
The working principle and fabrication of the lung-on-a-chip
were described previously (Stucki et al., 2015, 2018). Briefly,
the bioinspired lung-on-a-chip consists of an ultra-thin alveolar
membrane that is deflected by the action of a microdiaphragm
to mimic the mechanical strain of breathing (Figures 1A–C).
The alveolar membrane, on which cells can be cultured on
both sides, consists of a 3.5 µm–thick elastic membrane
(with or without 3µm pores, 800,000 pores/cm2) made of
polydimethylsiloxane (PDMS, Sylgard 184, Dow Corning). The
membrane is sandwiched between an apical and a basal
cell culture chamber. The microdiaphragm is a 40 µm–thick
membrane located at the bottom of the basal chamber and
actuated by an external electro-pneumatic system.
Cell Culture
A549 lung alveolar epithelial-like cells (ATCC cat#: CCL-185,
RRID:CVCL_0023) were cultured on fibronectin-coated PDMS
membranes (2.5 µg/cm2, Corning) in RPMI 1640 culture
medium with GlutaMAXTM (Gibco/Life Technologies, cat#:
61870-010) supplemented with 10% fetal bovine serum (FBS,
Gibco/Life Technologies, cat#: 10270-1 06) and 1% penicillin–
streptomycin (Gibco Life Technologies, cat#: 15140-122) at 37◦C
and 5% CO2. The cells were seeded at 50,000 cells/cm
2 on the
apical side of the alveolar membrane. Cell culture medium was
exchanged daily. When the cells reached confluence after 48 h,
they were cultured in starvation medium (RPMI 1640 without
FBS) for an additional 24 h.
Wound-Healing Assay
The epithelial cell monolayer was scratched by dragging a 10 µl
pipette tip across the thin membrane (Figures 2A–C). The cells
were washed once with starvation medium to remove cell debris.
The wounded monolayers were cultured for 24 h in starvation
medium with or without recombinant human hepatic growth
factor (rhHGF, 1, 10, or 100 ng/ml, R&D Systems, cat#: 294-
HG-05). In addition, cells were cultured either under static (no
stretch) or dynamic conditions (with three-dimensional stretch
corresponding to 10% linear strain at 0.2Hz).
Wound-Healing Analysis
Microscopic images of the entire wounded area were taken
immediately after wounding and 24 h later. Images taken
before wounding served as proof of confluence. The MosaicJ
(National Center for Microscopy and Imaging Research:
ImageJ Mosaic Plug-ins, RRID:SCR_001935) plug-in for Fiji
(RRID:SCR_002285) was used to stitch images together. The
wounded area was manually outlined based on images acquired
immediately after wounding and 24 h later. Only wounds with
areas between 1.2 and 2.5 mm2 were analyzed to ensure that data
would be comparable. Areas larger than 2.5 mm2 (one third of
the growth area) were excluded to ensure that sufficient cells were
present to repopulate the wounded area. Areas smaller than 1.2
mm2 were excluded to ensure that the wound was not completely
closed after 24 h.
Immunofluorescence Microscopy
Cells were immunostained for tight junctions using goat anti–
ZO-1 antibody (Abcam, cat#: ab99462) after fixation with 4%
paraformaldehyde (PFA, Sigma-Aldrich) and blocking with 2%
FBS in PBS. Hoechst-33342 (Molecular Probes, cat#: H3570) was
used to stain nuclei. Microscopic images were acquired using a
Zeiss Axioplan microscope with a 20× objective.
Scanning Electron Microscopy
Cells were fixed for 24 h in 2.5% glutaraldehyde (Sigma-
Aldrich) in 10mM HEPES buffer (Sigma-Aldrich). The cells
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FIGURE 1 | (A) Breathing concept in vivo. When the diaphragm contracts, negative thoracic pressure is generated and the lungs and lung alveoli expand. (B)
Breathing concept in vitro. A microdiaphragm deflects in a defined microcavity. Due to the negative pressure generated, the alveolar membrane, where the cells are
cultured, deflects downward. Schematic adapted from (Guenat and Berthiaume, 2018). (C) Image of the lung-on-a-chip with three culture chambers. Scale bar:
3mm. (D) Immunofluorescence image of A549 cells cultured on the membrane. Cell nuclei are stained in blue, and ZO-1 (a marker of tight junctions) is stained in red.
Scale bar: 20µm. (E,F) Scanning electron micrograph of A549 on non-porous (top) and porous (bottom) membranes. Scale bars: 50µm (top), 20µm (bottom).
FIGURE 2 | (A) Scheme of the scratch wound assay. The wound is created by scratching the cell-covered surface with a standard pipette tip. (B) Micrograph of
wounded A549 cells on a porous membrane. (C,D) Mosaic image of an entire wound immediately after wounding (C) and 24 h later (D). (E) Wound closure on
non-porous membranes, with or without cyclic stretch (CS, 10% linear, 0.2Hz), recombinant human hepatic growth factor (rhHGF, in ng/mL), or 10% fetal bovine
serum (FBS). Wound closure is promoted in a dose-dependent fashion by rhHGF, and impaired when CS is applied. (F) Wound closure is impaired when cells are
cultured under CS or on a porous membrane. Scale bars: 100µm.
were dehydrated using a sequence of ethanol concentrations (50–
100%). Before images were acquired, the samples were dried
using a critical point dryer (Baltec) and sputtered with gold.
Statistical Analysis
GraphPad prism (RRID:SCR_002798) was used for statistical
analyses. All data are shown as means ± standard deviation
(SD). A two-way ANOVA with Tukey correction for multiple
comparison was used to determine statistical significance.
RESULTS
Lung alveolar epithelial cells were successfully cultured on the
ultra-thin PDMS membrane. Figure 1D shows a confluent layer
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of cells stained with DAPI (nuclei) and anti–ZO-1 antibody
(tight junctions). Cells adhered to the membrane with their
filopodia spreading on the porous (Figure 1F) or non-porous
silicone membrane (Figure 1E). The elastic membrane resisted
the wound creation, where the cell layer was scratched with
a pipette tip, and did not tear, despite being only 3.5µm
thick (Figures 2A–C). In medium containing 10% FBS, wound
closure was complete after 24 h under both static (99.7%, n
= 4) and dynamic (99.9%, n = 3) conditions (Figure 2E).
Because FBS contains a plethora of growth factors, a starvation
medium without FBS was used to slow down the wound
closure and to measure the effect of HGF alone. In starvation
medium, alveolar epithelial wound closure was faster under
static than dynamic conditions (44.2 ± 7.6% with no stretching,
30.1 ± 9.5% with cyclic stretching, n = 5 and n = 6).
rhHGF exerted a dose-dependent positive effect on wound
closure, irrespective of culture conditions (static or dynamic).
In 10 ng/ml rhHGF, wound healing was markedly accelerated
under static conditions (44.2 to 66.6%, n = 3), and 100 ng/ml
rhHGF further increased the wound-healing rate, albeit only
slightly (n = 5). Under cyclic stress, a similar trend could be
observed at 1 ng/ml rhHGF (n = 4). At 100 ng/ml rhHGF,
wound closure improved from 30.1 to 38.8% (n = 6), almost
reaching the degree of initial wound closure observed under static
conditions.
When the cells were cultured on a porous membrane,
wound healing was also significantly slowed relative to a non-
porous membrane under static conditions (Figure 2F). With the
addition of cyclic stretching, wound healing was delayed further,
but not significantly compared to a non-porous membrane (n =
3 without stretch, n= 2 with stretch).
DISCUSSION
Wound-healing assays are widely used in drug discovery and
in fundamental investigation of the pathogenesis of wound
healing and of scar formation. Several organs, including the
skin and lung, are affected by diseases whose onset is related to
wounding. In the lung, IPF and acute lung injuries are severe
diseases for which the wound-healing mechanisms are crucial in
the development of the disease, but the cellular and molecular
mechanisms are not completely understood. Unfortunately, in
vivo models are of limited utility for investigating wound repair
in the lung, in part because it is not possible to induce single
small wounds and observe their repair over time. However,
standard in vitro techniques are also limited because they
poorly reproduce the in vivo milieu; instead, such systems often
consist of a monolayer of cells cultured on a hard substrate
and submerged in a static medium. The microenvironment of
the lung, by contrast, undergoes constant mechanical stimulus
induced by breathing motions. In addition, in a healthy lung,
epithelial cells are exposed to air, and the tissue contains many
other cell types. Recent advances in microengineering and cell
biology have made it possible to develop advanced systems that
mimic these properties (Huh et al., 2010; Stucki et al., 2015,
2018). We therefore assume that this in vitro model of epithelial
wound repair including mechanical forces represents the in vivo
situation at a higher level than conventional in vitro model
systems.
Here, we performed a proof-of-concept study of a wound-
healing assay on a lung-on-a-chip. Applying cyclic mechanical
stretch reduced the wound-healing capabilities of alveolar cells
over 24 h, consistent with studies of human bronchial cells and
alveolar epithelial cells in rodents and humans (Desai et al.,
2010; Crosby et al., 2011; Ito et al., 2014). The impaired wound
closure was partially restored by the addition of rhHGF. This
effect was concentration-dependent in all conditions, confirming
earlier results (Felder et al., 2012, 2014; Ito et al., 2014). The
mechanism underlying the impaired wound repair upon stretch
is not completely understood. Desai et al. showed that cyclic
stretch corresponding to 20% linear strain at 0.5Hz inhibited
phosphatidylinositol 3-kinase (PI3K) in bronchial epithelial cells
(Desai et al., 2010). PI3K is typically activated in wound healing.
However, Ito et al. did not observe the same downregulation
in PI3K when alveolar cells were subjected to only 10% linear
strain at 0.1Hz (Ito et al., 2014). These discrepancies suggest
that different pathways may be involved in wound healing
depending on the stretch magnitude and frequency. However,
other players, such as stiffness, which can importantly affect
the strain level, are involved in IPF remodeling (Selman and
Pardo, 2014). In the present lung-on-a-chip, the stiffness of
the membrane may be modified in the future to mimic this
aspect.
Furthermore, we observed reduced wound healing on a
porous membrane (3µm pores, 800,000 pores/cm2) relative to
a non-porous membrane, regardless of cyclic stretch. This can
be partially explained by the fact that, on porous membranes,
there is no continuous cell support. The interaction between
cells and the extracellular matrix (ECM) plays an important
role during growth, development and repair (Rosso et al., 2004).
The absence of this ECM–cell interaction where the pores are
located may slow down cell migration. Furthermore, A549 cells
are capable of transmigrating through the 3µmpores to the other
side of the membrane and are thus not involved in the wound
closure.
The semi-open design of the lung-on-a-chip provides an
easy access to the apical cell culture well. Consequently, the
cell layer can simply be wounded with a pipette tip, and
wound healing can be observed during cyclic mechanical
stretching. To the best of our knowledge this is the first
report of a wound-healing assay performed on an ultra-thin,
porous, and stretchable membrane. This system enables the
development of more complex assays that can so far not be
reproduced.
Preliminary results culturing epithelial cells with fibroblasts
(see Supplementary Materials) show that wound-healing of a
co-culture model can be investigated with this device. This is
of great importance to study the pathophysiology of interstitial
lung diseases. By further adding immune cells and/or endothelial
cells, other biological questions may be investigated. In addition
to the cyclic stress, other aspects of the unique lung alveolar
environment can be emulated. Notably, the air-liquid interface,
which all healthy pulmonary epithelial cells are exposed to.
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In such configuration, the epithelial layer receives its nutrients
via the basolateral side of the membrane (through endothelial
cells) while being exposed to air on the apical side. The
reproduction of these key environmental aspects may help to
fully elucidate the complex interplay between mechanical strain
and deficient alveolar wound repair that underlies IPF and
other diseases. By culturing diseased cells from patients, our
hope is to be able to develop cell-based assays for precision
medicine.
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